AbbVie has never been shy about guarding its patents and hiking drug prices. Congress tore into the company this week. But will it lead to any real policy change? Read More
Related Articles
Petco rebrands, bans shock collars in health and wellness push
The COVID-19 pandemic that has led to a surge in pet adoptions and spending on our furry mascots has also made the pet care field so crowded that it’s even more difficult for retailers like Petco to stand out from the pack. To that end, the big box pet products chain announced on Tuesday it […]
The Way A.I. and Innovative Technology Have Been used to stop the spread of COVID-19
Kimberly Powell, vice president and general manager of healthcare at Nvidia, believes that the firm, in consequence, is building machines. Using artificial intelligence and supercomputing to radically shorten the time physicians and researchers devote diagnosing ailments and growing antiviral medication remedies, Nvidia, that got its start as a chipmaker for video gamesand has played an […]
Nearly 200 business leaders deliver strong message to Congress: Certify Biden’s presidency
Business leaders around the country are uniting to urge Congress to certify a win by President-elect Joe Biden without delay, arguing that any attempt to “thwart” the process would “run counter to the essential tenets of our democracy.” On Monday afternoon nearly 200 leaders signed the short, open letter asking legislators to certify Biden’s presidency […]